GlassScriptPhysician profile
Megan M Zaander
NPI 1801039623
$1,256.34
in general payments reported to CMS, 2019-2025
25 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $74.56 · 2021: $150 · 2022: $346 · 2023: $225 · 2024: $244 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.22 | 2019-2024 | Liletta |
| Hologic Sales and Service, LLC | $131.84 | 2021-2024 | Omni Hysteroscope, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $98.42 | 2019-2022 | |
| Coopersurgical, INC. | $93.24 | 2019-2022 | |
| Medtronic, INC. | $88.53 | 2022-2024 | Truclear |
| Applied Medical Resources Corporation | $73.16 | 2023 | Gelpoint V-Path |
| Mayne Pharma Commercial LLC | $64.79 | 2022-2025 | |
| Myovant Sciences INC. | $48.13 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.51 | 2020-2024 | |
| Exact Sciences Corporation | $43.37 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $39.18 | 2022-2024 | Twirla |
| Pfizer INC. | $33.09 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $32.60 | 2019-2021 | |
| Astellas Pharma US INC | $26.37 | 2024 | Veozah |
| Becton, Dickinson and Company | $23.95 | 2024 | Bd Onclarity |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $23.93 | 2025 | Slynd |
| Minerva Surgical, INC | $23.66 | 2023 | |
| Vertical Pharmaceuticals, LLC | $21.37 | 2019 | |
| Conmed Corporation | $20.44 | 2025 | Airseal |
| Organon LLC | $20.35 | 2025 | Nexplanon |
| Baxter Healthcare | $19.86 | 2023 | Tisseel |
| Sumitomo Pharma America, INC. | $18.81 | 2024 | Myfembree |
| Novo Nordisk INC | $17.69 | 2023 | Wegovy |
| Lupin INC. | $17.38 | 2020 | |
| Axonics, INC. | $16.45 | 2024 | Bulkamid, Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Zaander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.